The effect of post-Brexit status on clinical trial logistics
One year on from Brexit, Clinical Trials Arena talks to Oximio about the impact of the trade agreement on clinical…
In association with Oximio
The next chapter of clinical trial services
Latest in
The next chapter of clinical trial services
Africa’s last mile: Building viable vaccine supply chains
Lack of access to vaccines leads to 1.5 million preventable deaths each year[1]. In Africa alone, approximately one in five…
Lifesaving logistics: overcoming barriers to expanded access programs
Expanded access programs (EAPs), have been in and out of the pharmaceutical spotlight since their inception back in the late…
The logistics of extending the footprint of advanced therapy trials
Most advanced therapy medicinal products (ATMPs, also known as cell and gene therapies) address the clinical needs of “orphan” diseases…
Design for life: How to optimise costs and innovation in clinical trials using global sourcing strategies
No one has ever said that running clinical trials is easy. Rather, studies are arguably increasing in complexity due to…
Seven trends and market changes affecting clinical trials in 2021
The last 12 months were full of challenges for trial sponsors and the clinical trials market saw dynamic change when…
Oximio announces new Chief Operating Officer
Clinical trial services provider, Oximio, announced in March that Peter Szabados has been appointed as the Chief Operating Officer (COO),…
The SMO Group announces company name change to Oximio
The global clinical trial services provider The SMO Group announced earlier this year that the company will begin operating under…
Oximio’s breath of fresh air
Transformation is an overused word in the modern business lexicon, so it’s refreshing to hear a business leader, in the midst of…
A new brand in clinical trial logistics
Founded in 2004, the SMO Group has a strong heritage in clinical trial logistics. Now, it is entering the next…